Jagsonpal Pharmaceuticals Limited (NSE:JAGSNPHARM)
India · Delayed Price · Currency is INR 233.00
+1.11 (0.48%)
Jul 10, 2026, 3:29 PM IST
Jagsonpal Pharmaceuticals Market Cap
Jagsonpal Pharmaceuticals has a market cap or net worth of 15.63 billion as of July 10, 2026. Its market cap has increased by 9.55% in one year.
Market Cap
15.63B
Enterprise Value
14.65B
Revenue
2.87B
Ranking
n/a
PE Ratio
36.89
Stock Price
233.00
Market Cap Chart
Since March 1, 2000, Jagsonpal Pharmaceuticals's market cap has decreased from 17.63B to 15.63B, a decrease of -11.36%. That is a compound annual growth rate of -0.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 15.63B | 21.50% |
| Dec 31, 2025 | 12.86B | -20.68% |
| Dec 31, 2024 | 16.22B | 58.61% |
| Dec 29, 2023 | 10.22B | 4.69% |
| Dec 30, 2022 | 9.77B | 108.36% |
| Dec 31, 2021 | 4.69B | 150.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Innova Captab | 56.62B |
| Orchid Pharma | 51.36B |
| RPG Life Sciences | 47.25B |
| Solara Active Pharma Sciences | 27.41B |
| Indoco Remedies | 24.02B |
| Beta Drugs | 23.89B |
| Ind-Swift Laboratories | 21.37B |
| Sakar Healthcare | 18.35B |